STOCK TITAN

Tang Capital (ALT) reports 666,022 shares, 0.3% stake in Altimmune (ALT)

(Neutral)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Altimmune, Inc. Schedule 13G/A reports that Tang Capital Management, LLC and related entities and persons beneficially own 666,022 shares of common stock, representing 0.3% of the class. The filing states the percent is calculated from 194,199,358 shares outstanding as of April 24, 2026 as shown in a prospectus filed on April 24, 2026. The filing lists shared voting and dispositive power among Tang Capital Management, LLC, Tang Capital Partners International, LP, and Kevin Tang, and affirms the position falls within the "Ownership of 5 Percent or Less of a Class" category.

Positive

  • None.

Negative

  • None.

Insights

Minor passive stake filed via Schedule 13G/A; shared control noted.

The filing shows a 666,022-share holding, equal to 0.3% of common stock based on 194,199,358 shares outstanding as of April 24, 2026. Ownership is reported as shared voting and dispositive power among TCM, TCPI, and Kevin Tang.

Because the position is under 5%, it is reported on a passive/beneficial basis under the Schedule 13G/A framework. Subsequent filings would disclose any material change in stake or control.

Beneficially owned shares 666,022 shares Amount beneficially owned reported in Schedule 13G/A
Percent of class 0.3% Percent of common stock based on outstanding shares
Shares outstanding used 194,199,358 shares Outstanding shares as of April 24, 2026 (prospectus basis)
Schedule 13G/A regulatory
"This Statement on (this "Statement") is filed by TCM"
A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.
beneficially own financial
"Item 4. | Ownership (a) | Amount beneficially owned: 666,022"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
shared voting and dispositive power regulatory
"shares voting and dispositive power over such shares with Tang Capital Partners International, LP"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What stake does Tang Capital Management report in ALT?

Tang Capital Management and related persons report 666,022 shares, representing 0.3% of Altimmune's common stock based on 194,199,358 shares outstanding as of April 24, 2026.

Who shares voting and dispositive power over the reported ALT shares?

The filing states shared voting and dispositive power is held by Tang Capital Management, LLC, Tang Capital Partners International, LP, and Kevin Tang over the 666,022 shares.

Is the reported ALT position greater than 5%?

No. The filing classifies the holding under "Ownership of 5 Percent or Less of a Class," reporting a 0.3% ownership stake of common stock.

What outstanding-share figure does the filing use to calculate the percentage?

The percentage is calculated using 194,199,358 shares outstanding as of April 24, 2026, cited from a prospectus filed on April 24, 2026.

Which entities and addresses are listed for the filers in the Schedule 13G/A?

Addresses listed: 4747 Executive Drive, Suite 210, San Diego, CA 92121 for TCM, Kevin Tang, TCP and TCPI; 400 S. 4th Street, 3rd Floor, Las Vegas, NV 89101 for TCP III and TCP IV.





02155H200

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: Tang Capital Management, LLC ("TCM") shares voting and dispositive power over such shares with Tang Capital Partners International, LP ("TCPI") and Kevin Tang. The percentages used herein are based on 194,199,358 shares of Common Stock outstanding as of April 24, 2026, as set forth in the Prospectus filed on Form 424B5 that was filed with the Securities and Exchange Commission on April 24, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: Kevin Tang shares voting and dispositive power over such shares with TCPI and TCM.


SCHEDULE 13G





SCHEDULE 13G




Comment for Type of Reporting Person: TCPI shares voting and dispositive power over such shares with TCM and Kevin Tang.


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



TANG CAPITAL MANAGEMENT, LLC
Signature:/s/ Kevin Tang
Name/Title:Manager
Date:05/15/2026
KEVIN TANG
Signature:/s/ Kevin Tang
Name/Title:Self
Date:05/15/2026
TANG CAPITAL PARTNERS, LP
Signature:/s/ Kevin Tang
Name/Title:Manager, Tang Capital Management, LLC, General Partner
Date:05/15/2026
TANG CAPITAL PARTNERS INTERNATIONAL, LP
Signature:/s/ Kevin Tang
Name/Title:Manager, Tang Capital Management, LLC, General Partner
Date:05/15/2026
TANG CAPITAL PARTNERS III, INC
Signature:/s/ Kevin Tang
Name/Title:Chief Executive Officer
Date:05/15/2026
TANG CAPITAL PARTNERS IV, INC
Signature:/s/ Kevin Tang
Name/Title:Chief Executive Officer
Date:05/15/2026